The molecular organization of presynaptic active zones is important for the neurotransmitter release that is triggered by depolarization-induced Ca 21 influx. Here, we demonstrate a previously unknown interaction between two components of the presynaptic active zone, RIM1 and voltage-dependent Ca 21 channels (VDCCs), that controls neurotransmitter release in mammalian neurons. RIM1 associated with VDCC b-subunits via its C terminus to markedly suppress voltage-dependent inactivation among different neuronal VDCCs. Consistently, in pheochromocytoma neuroendocrine PC12 cells, acetylcholine release was significantly potentiated by the full-length and C-terminal RIM1 constructs, but membrane docking of vesicles was enhanced only by the full-length RIM1. The b construct beta-AID dominant negative, which disrupts the RIM1-b association, accelerated the inactivation of native VDCC currents, suppressed vesicle docking and acetylcholine release in PC12 cells, and inhibited glutamate release in cultured cerebellar neurons. Thus, RIM1 association with b in the presynaptic active zone supports release via two distinct mechanisms: sustaining Ca 21 influx through inhibition of channel inactivation, and anchoring neurotransmitter-containing vesicles in the vicinity of VDCCs.
The presynaptic active zone is the specific site for impulse-evoked exocytosis of neurotransmitters at synapses of the nervous system in a wide variety of species 1, 2 . Fine regulation of presynaptic active zone neurotransmitter release is integral to nervous system adaptive functions, including learning, memory and cognition. The molecular organization of presynaptic active zones, where synaptic vesicles are docked in close vicinity to VDCCs at the presynaptic membrane, is essential for controlling the neurotransmitter release triggered by depolarization-induced Ca 2+ influx. The spacing between VDCCs and vesicles influences the dynamic properties of synaptic transmission 3 . However, the molecular determinants that maintain vesicles and VDCCs within a physiologically appropriate distance have remained elusive.
Originally identified as a putative effector for the synaptic vesicle protein Rab3 (ref. 4) , RIM1 is part of the RIM superfamily, whose members share a common C 2 B domain at their C termini 5 . RIM1 interacts with other presynaptic active zone protein components, including Munc13, ELKS (also known as CAST), RIM-BP and liprins, to form a protein scaffold in the presynaptic nerve terminal [6] [7] [8] [9] [10] . Mouse knockouts showed that, in different types of synapses, RIM1 is essential for different forms of synaptic plasticity 9, 11 . In the CA1-region Schaffer-collateral excitatory synapses and GABAergic synapses, RIM1 maintains normal neurotransmitter release and short-term synaptic plasticity. In excitatory CA3-region mossy fiber synapses and cerebellar parallel fiber synapses, RIM1 is necessary for presynaptic long-term synaptic plasticity. In autapses, the RIM1 deletion significantly reduces the readily releasable pool of vesicles, and it alters shortterm plasticity and the properties of evoked asynchronous release 12 . However, in spite of this progress in understanding RIM1 functions, the mechanisms by which RIM1 acts remain unknown. Moreover, the physiological functions of other RIM isoforms (RIM2, RIM3 and RIM4) 5 remain unclear.
Multiple types of VDCCs that are distinguished on the basis of biophysical and pharmacological properties coexist in neurons 13 . High voltage-activated types of VDCCs that are essential for neurotransmitter release include N-, P/Q-, R-and L-types [14] [15] [16] . VDCCs are heteromultimeric protein complexes composed of the pore-forming a 1 , designated as Ca v , and auxiliary subunits a 2 /d, b and g 17 . The a 1 subunit is encoded by ten distinct genes, whose correspondence with functional types is largely elucidated 13, 17 . VDCC complexes are associated, primarily via interactions with the a 1 subunit [18] [19] [20] [21] [22] [23] [24] [25] , with presynaptic and postsynaptic proteins including syntaxin, SNAP-25, synaptotagmin, CASK and Mint. The a 1 and b subunits interact to enhance functional channel trafficking to the plasma membrane 26, 27 and to modify multiple kinetic properties 28 ; the b subunit also interacts with other proteins [29] [30] [31] . Therefore, it is intriguing to investigate whether b subunits are involved in targeting VDCC complexes to specific subcellular machinery at presynaptic active zones for neurotransmitter release through as yet unidentified interactions. Here, we demonstrate a previously unknown molecular interaction between RIM1 and VDCC b subunits, both of which are essential presynaptic active zone proteins. The RIM1-b interaction supports the function of RIM1 in neurotransmitter release via two distinct mechanisms: the anchoring of neurotransmitter-containing vesicles in the vicinity of VDCCs, and the sustenance of Ca 2+ influx through the inhibition of voltage-dependent inactivation.
RESULTS

VDCC b subunits directly interact with RIM1
To identify b subunit-interacting proteins that regulate presynaptic active zone organization, we performed yeast two-hybrid screening with a mouse brain complementary DNA library using the full-length rat b 4b subunit as a bait. The b 4 subunit was chosen because spontaneous b 4 mutant Cacnb4 lh (lethargic) mice 32 have clear neurological defects suggesting that b 4 -containing VDCCs are physiologically significant in the brain. Screening identified a clone (no. [2] [3] [4] [5] encoding the C-terminal region (residues 1079-1463) of the mouse RIM1 protein 4 including the C 2 B domain (Fig. 1a) . Subsequent two-hybrid assays using b 4b mutants showed that residues 49-410, containing major structural motifs such as the Src homology 3 (SH3) domain, the a 1 -interacting domain known as BID and the guanylate kinase (GK) domain, were required for the interaction of b 4b with the RIM1 C terminus (Fig. 1b) . b 2a also showed RIM1 interaction. In vitro pulldown assays using glutathione-S-transferase (GST) fusion constructs identified the RIM1 C terminus (residues 1079-1463) as a major b 4 -interaction domain likely formed in concert by two adjacent subdomains (1079-1257 and 1258-1463; Fig. 1c and Supplementary  Fig. 1 online) . An in vitro binding assay using purified b 4 and RIM1 recombinants revealed a dissociation constant (K d ) of 35.1 nM for RIM1 , which was substantially lower than those of RIM1 1079-1257 (481 nM) and RIM1 1258-1463 (717 nM) ( Fig. 1d and Supplementary Fig. 2 online) . These results, as well as the successful coimmunoprecipitation of full-length RIM1 with b 4b (Fig. 1e) , suggest that a direct protein-protein interaction occurs between RIM1 and b 4 .
RIM1 physically associates with native VDCCs in the brain
We characterized the association between native VDCCs and RIM1 biochemically using VDCC complexes enriched from mouse brains through microsome preparation, KCl wash, solubilization, heparin purification and sucrose density gradient fractionation 25 . Western blot analysis of sucrose gradient fractions showed cosedimentation of RIM1 with Ca v 2.1 and b 4 (Fig. 2a) . Statistical analysis of cosedimentation data revealed a complete overlap of Ca v 2.1 and b 4 , confirming that they associate in the VDCC complex (Fig. 2b) . RIM1 sedimented in overlapping minor and major peaks: the latter completely overlapped with VDCC subunits, whereas the former did not cosediment with VDCC and is likely to represent a subset of RIM1 in a smaller, GST-RIM1 GST-RIM1 
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non-VDCC complex. Syntaxin, a VDCC-interacting protein [18] [19] [20] [21] , showed similar cosedimentation with RIM1. Immunoprecipitation analysis of heparin-purified samples confirmed that the cosedimentation of RIM1 is due to its specific interaction with VDCC subunits (Fig. 2c) . Antibody specific for b 4 precipitated RIM1 from wild-type mice, but not from lethargic mice (which carry a mutated form of the gene Cacnb4), expressing truncated b 4 protein lacking the a 1 -interacting region 32, 33 . It is unlikely that the b 4 isoform exclusively mediates the RIM1-VDCC association in the brain, as wild-type and lethargic mice were indistinguishable in the sucrose gradient profile (Fig. 2d) . We designed a dominant-negative suppressor b 4b fusion construct (beta-AID dominant negative, BADN) to dissociate the activity of b-binding proteins such as RIM1 from the functional VDCC complex (Supplementary Fig. 3 online) . As residues 49-410 of the entire 519-aminoacid b 4b sequence are required for RIM1 binding (Fig. 1b) , BADN was designed from the 'full-length' b 4b to efficiently quench RIM1. BADN also carries the b-interacting AID region from Ca v 2.1 buried at the a 1 -binding site 33 . Because the intermolecular association of BADN with VDCC a 1 is inhibited by the intramolecular occlusion of the a 1 -binding site in BADN, overexpression of BADN should deprive native b subunits of RIM1 without affecting their association with a 1 . In vitro binding and coimmunoprecipitation experiments showed that BADN could bind to RIM1, but not to the AID-containing I-II linker region of Ca v 2.1 ( Supplementary Fig. 3) . Notably, the native RIM1-b association in partially purified brain VDCCs was disrupted by an 8-h co-incubation with 100 nM GST fusion proteins for BADN or RIM1 (Fig. 2e) . In vitro binding of b 4 to RIM1 1079-1463 rapidly decayed with the addition of excess BADN (200 nM), indicating that this disruption is attributable to displacement of binding partners in the native association ( Supplementary Fig. 3 ). These results provide evidence for a physiological association between native RIM1 and P/Q-type VDCCs via the b subunit in brain.
RIM1 targets to VDCC via b subunits at the plasma membrane
In recombinant HEK293 cells, b 4b and RIM1 were concentrated at the plasma membrane when they were coexpressed with the P/Q-type Ca v 2.1 a 1 subunit, whereas they were diffusively colocalized throughout the intracellular area in the absence of Ca v 2.1 ( Fig. 3a and Supplementary Fig. 4 online). The ratio of the fluorescence intensity at the plasma membrane, PM, to that in the cytoplasm, CYT-F PM / F CYT -was 0.52 ± 0.07 and 0.48 ± 0.07 with Ca v 2.1 and 0.10 ± 0.02 and 0.08 ± 0.02 without Ca v 2.1 for b 4b and RIM1, respectively. RIM1 localization to the plasma membrane via a membrane-targeted b-binding domain 27 composed of CD8 and the Ca v 2.1 I-II linker was elicited only after b 4b expression ( Fig. 3b and Supplementary  Fig. 4 ). In cultured hippocampal neurons, RIM1 and b 4b both accumulated near presynaptic termini, in parallel with Ca v 2.1 clustering. These events had a substantially later onset than synaptogenesis, as shown by the synapsin I clustering observed at 8 days in vitro (DIV, Fig. 3c,d ). Quantitative imaging showed that overexpression of either BADN or the RIM1 C terminus, RIM1 1079-1463 , impaired the Ca v 2.1 clustering in presynaptic varicosities (Fig. 3e,f) . The coincident targeting of RIM1 and b 4b , as well as the blockade of Ca v 2.1 accumulation by quenching of RIM1 and bs, suggests that the RIM1-b interaction regulates the localization of VDCCs at the presynaptic membrane. Because RIM1 interacts with multiple proteins (Fig. 1a) , the RIM1 effect observed using BADN and RIM1 1079-1463 could also be attributed to the quenching of other RIM interactions at different subcellular locations. However, a recent immunostaining study showed that the staining intensities for Ca v 2.2 and RIM covary at a giant calyx-type synapse 34 , consistent with the idea that they are both components of transmitter release sites.
RIM1-b interaction modulates inactivation of VDCCs
To elucidate the functional significance of direct RIM1-b 4 coupling, we characterized whole-cell Ba 2+ currents through recombinant VDCCs expressed as a 1 a 2 /db complexes containing various neuronal a 1 subunits: N-type Ca v 2.2, P/Q-type Ca v 2.1, R-type Ca v 2.3 and L-type Ca v 1.2 channels in BHK cells. The most prominent RIM1 effect on VDCC currents was observed on inactivation parameters. Inactivation was markedly decelerated in N-, P/Q-, R-and L-type currents (Fig. 4a,b) . The same set of VDCC types also showed a significant depolarizing shift in the voltage dependence of inactivation ( Fig. 4c,d ; see Supplementary Table 1 for statistical significance). In P/Q-type currents (with b 4b ), RIM1 shifted the half-inactivation potential (V 0.5 ) by +24.6 mV, eliciting an inactivation curve with a component that was susceptible to inactivation induced at high voltages (V 0.5 (vector) ¼ -45.9 mV, V 0.5 (RIM1) ¼ -21.3 mV) and a component that was noninactivating. In N-and R-type currents, RIM1 provoked a switch in the major phase of biphasic inactivation curves from low voltage induced (V 0.5 and ratio: -64.5 mV and 0.91 for N, and -78.2 mV and 0.91 for R) to high voltage induced (V 0.5 and ratio: -20.8 mV and 0.61 for N, and -27.9 mV and 0.53 for R). The L-type inactivation curve remained monophasic; however, the non-inactivating component was significantly augmented by RIM1 (from 0.07 to 0.25; P o 0.05). In P/Q-type, similar RIM1 effects on inactivation were observed with all other b subunits tested ( 
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(with b 1a ) current inactivation (Fig. 4a,c and Supplementary Table 3 online) .
After RIM1 coexpression, single-channel P/Q-type currents clearly showed a prolongation of the mean time between first channel opening and last closing within a trace during 750-ms depolarizations to +20 mV without substantial changes in amplitude (0.59 pA, Fig. 4e ). This observation corresponds well with the whole-cell data and suggests that RIM1 predominantly stabilizes the non-inactivating mode 35 . Currents evoked by trains of action potential waveforms, a more physiological voltage-clamp protocol used to determine closedstate inactivation 36 , further support the existence of a profound suppression of voltage-dependent inactivation by RIM1 (Fig. 4f) .
The observed effect of RIM1 on VDCC inactivation is attributable to its association with the b subunit, as replacement of b 4 with the C-terminal truncation construct b 4 -GK 37 , which directly interacts with a 1 but lacks the ability to bind RIM1, did not substantially affect inactivation of N-type currents ( Supplementary Fig. 5 and Supplementary Table 4 online). In addition, BADN significantly diminished the RIM1 effect on P/Q channel inactivation ( Supplementary Fig. 5 and Supplementary Table 5 online for statistical significance). When 5 mM Ca 2+ was used as a physiological charge carrier capable of inducing both Ca 2+ -dependent and voltage-dependent inactivation 38 , RIM1 still exerted prominent suppressive effects on inactivation in P/Q-type currents expressed in HEK293 cells (Fig. 5a,b and Supplementary Table 6 online). Notably, in rat PC12 neuroendocrine cells, BADN or application of siRNAs that specifically suppress RIM1 and RIM2 expression accelerated inactivation and shifted the inactivation curve toward the hyperpolarizing direction (Fig. 5c,d and Supplementary Table 7 online). This supports a physiologically significant role for RIM-mediated VDCC modulation via the b subunit. Notably, as observed in RIM1-expressing cells, voltage-dependent inactivation of presynaptic VDCC currents at membrane potentials Z-40 mV has been previously demonstrated 39 . Thus, RIM1 exerts strong suppressive effects on the kinetics and voltage dependence of inactivation of VDCC currents.
RIM1's effects on other functional current parameters such as voltage dependence of activation, activation kinetics and current densities at different voltages in current-voltage relationships differentiate VDCCs into two different groups (Fig. 6 and Supplementary Table 1 ). In b 4b -expressing BHK cells, the current densities of N-and P/Q-type currents were significantly augmented by RIM1, whereas those of R-and L-type currents were unaffected by RIM1 (Fig. 6c,d ; and see Supplementary Table 1 for statistical significance). In P/Q-type, RIM1 1079-1463 , which binds b, was sufficient to enhance current density (Fig. 6c) . By contrast, activation speeds were significantly reduced and activation curves were shifted toward positive potentials by RIM1 in R-and L-types, but not in N-and P/Q-types ( Fig. 6a,b ; and see Supplementary Table 1 for statistical significance). Replacement of b 4b with other b isoforms abolished the augmentation of P/Q-type current densities by RIM1 ( Supplementary Fig. 6 online) , but slowed the activation speed of P/Q-type by RIM1 (Fig. 6b) . The RIM1 positive shift in activation curve was also elicited by b 2a in P/Q-type ( Supplementary Fig. 6 ). Thus, N-and P/Q-type currents responded differently to RIM1 in terms of activation parameters and current densities than did R-and L-type currents, perhaps reflecting different subcellular localizations or functions of these channel subsets.
RIM1-b binding anchors neurotransmitter vesicles to VDCCs
We directly observed vesicles docked to the plasma membrane using evanescent wave microscopy, which illuminates only the subcellular area from the surface to a depth of less than 100 nm by total internal reflection fluorescence (TIRF). Dense-core vesicles were identified by a fusion protein of neuropeptide Y (NPY) and the fluorescent protein Venus in PC12 cells. The overlapping distribution of NPY-Venus, VAMP-DsRed-monomer and RIM1-DsRed-monomer indicated that transmitter-filled synaptic vesicles can be identified using the fluorescent signals of NPY-Venus (Fig. 7a) . The codistribution is likely to be specific for RIM1, as caveolin-1-enhanced green fluorescent protein (EGFP) did not colocalize with VAMP-DsRed-monomer. The number of docked vesicles was increased significantly by expression of the fulllength RIM1 (P o 0.001), whereas it was unaffected by RIM1 400-1078 or by RIM1 , which forms a ternary complex with Rab3 and Munc13 via a Zn 2+ finger critical for neurotransmitter release 40 (Fig. 7b,c) . BADN, as well as RIM1 , significantly attenuated the number of docked vesicles (P o 0.001 for BADN, P o 0.05 for RIM1 ). These inhibitory effects of BADN and RIM1 1079-1463 on vesicle docking most likely occur by quenching endogenous full-length RIMs and by saturating RIM1 interaction sites on VDCC b subunits, respectively. The BADN effect is not due to a reduction in the densities of VDCCs in PC12 cells, as BADN did not substantially affect current densities (Fig. 5c) . Thus, the 'full-length' structure is probably essential for RIM1 to anchor neurotransmitter vesicles to VDCCs. Table 7 for statistical significance of the differences. Right, comparison of current densities at 10 mV (n ¼ 6 and 8 cells, for siControl, and siRIM1 and siRIM2, respectively).
RIM1-b interaction enhances neurotransmitter release
We studied the physiological relevance of RIM1 interactions with the VDCC complex by assessing neurotransmitter release from PC12 cells in which diverse high voltage-activated VDCC types have been precisely characterized 35, 41 ( Supplementary Fig. 7 online) . We transfected PC12 cells with RIM1 construct cDNAs along with Chat (encoding choline acetyltransferase), which synthesizes acetylcholine (ACh) for synaptic vesicles 42 . ACh release, triggered by Ca 2+ influx in response to high-K + (elevation of extracellular K + concentration from 5.9 mM to 51.1 mM) membrane depolarization, was significantly potentiated by full-length RIM1 ( Fig. 8a and Supplementary Fig. 7 , P o 0.001). ACh release was also enhanced by the Rab3-interacting N-terminal RIM1 and by the C-terminal RIM1 1079-1463 that maintains VDCC currents, but not by the middle RIM1 400-1078 . In contrast, BADN significantly suppressed ACh release (P o 0.001). In cultured cerebellar neurons, similar suppression by BADN and potentiation by the fulllength RIM1 were observed for high K + -induced glutamate release (Fig. 8b) . The results suggest that RIM1 potentiates neurotransmitter release through its interaction with VDCC b in neuronal and neuron-like cells.
DISCUSSION
The present investigation reveals a previously unknown physical association between the presynaptic active zone proteins RIM1 and VDCC b subunits. The results of yeast two-hybrid assays, in vitro binding assays and coimmunoprecipitation experiments have identified a RIM1-VDCC complex formed by direct interaction of the b subunit with the a 1 subunit AID region and the RIM C terminus (residues 1079-1463) (Fig. 1) . The identification of native RIM1-VDCC complexes in brain (Fig. 2) , the colocalization of RIM1 with VDCC subunits at the plasma membrane and the presynapse, and the disruption of such localization and complex formation by BADN (Fig. 3) support a physiological role for the RIM1-b association.
Further biochemical and functional analyses (Figs. 1 and 4) suggest that RIM1 1079-1257 and RIM1 1258-1463 are the primary b subunit binding site and modulatory region, respectively, in the RIM1 protein.
Although our experiments showed that RIM1 and b 4 interacted, the RIM1 in wild-type brains was indistinguishable from that found in the brains of lethargic mice by sucrose gradient profile (Fig. 2a,d ). neurons are indistinguishable between wild-type and lethargic mice 32 . This has been attributed to the rescue of b 4 deficiency by the remaining subunits, b 1 , b 2 and b 3 . We expect a similar compensatory mechanism may also occur in the RIM1-b interaction in lethargic mice. Therefore, the b 4 isoform is unlikely to exclusively mediate the RIM1-VDCC association in the brain. The RIM1-b association enables RIM1 to have a dual physiological function in neurotransmitter release: sustaining Ca 2+ influx through the functional regulation of VDCCs and anchoring vesicles to VDCCs ( Supplementary Fig. 8 online) . Among the functional parameters of VDCCs, those that are related to voltage-dependent inactivation are most prominently modified by RIM1 through the b interaction (Fig. 4) . The inactivation kinetics are markedly decelerated, resulting in the predominance of high-voltage inactivation and an inactivationresistant current component in the 2-s prepulse protocol. The similarly modulated inactivation properties of P/Q-type VDCCs by RIM2a, RIM3g or RIM4g (unpublished data), which all carry the C 2 B domain, suggest that this function is a common feature for the RIM family 5 . Suppression by BADN of the RIM1-mediated inactivation in both the recombinant ( Supplementary Fig. 5 ) and native VDCCs (Fig. 5c) provides evidence that RIM1 exerts observed effects through the RIM1-b association. This is supported by our finding that b 4 -GK, which binds to a 1 (ref. 37 ) but not to RIM1, did not mediate RIM1 effects on N-type channels ( Supplementary Fig. 5 ). Although the detailed molecular mechanisms underlying inactivation have yet to be determined, previous mapping of the molecular determinants for voltage-dependent inactivation kinetics 43 suggest that RIM1-b complexes bound to the I-II linker AID further act on adjacent segment S6 of repeat I to hinder its conformational transition to the inactivated state. Alternatively, RIM1 may immobilize the b subunit and the process of inactivation by slowing the movement of the I-II loop 44, 45 . When voltage-dependent inactivation is thus suppressed, the responses of Ca 2+ sensors such as synaptotagmins to Ca 2+ influx may be potentiated at depolarizing membrane potentials that induce voltage-dependent inactivation when RIM1 is absent. Because RIM1 virtually abolished VDCC inactivation that was elicited by a train of action potential waveforms (Fig. 4f) , certain forms of synaptic depression via closed-state inactivation 36 may be minimized by RIM1 at presynaptic active zones. The impact of the RIM1-b association on delaying VDCC inactivation may explain recent findings with the RIM1a knockout mouse showing that RIM1 is important for the late-stage asynchronous neurotransmitter release, whereas synaptotagmin I is involved in the earlier synchronous release 12 . With P/Q-and N-type channels, the RIM1-b association significantly affected channel activity as well; current densities were nearly doubled by RIM (Fig. 6c) . Thus, RIM1 can maintain and enhance depolarization-induced Ca 2+ influx to support neurotransmitter release at presynaptic active zones.
Regarding the role of RIM1 in vesicle anchoring to VDCC at the plasma membrane, full-length RIM1 is required to mediate vesicle anchoring, in contrast to the RIM1 suppression of VDCC inactivation, which requires only the RIM1 C terminus. Taking into consideration the direct RIM1-Rab3 association and the regulation of tethering and/ or priming of synaptic vesicles by Rab3 (ref. 40) , it is likely that simultaneous interactions of RIM1 with vesicle-associated Rab3 and Munc13 via the N-terminal Zn 2+ -finger domain and with the VDCC b subunit via the C-terminal C 2 B domain underlie, at least in part, the maintenance of the close proximity of VDCCs to vesicles, thereby regulating the dynamic properties of synaptic transmission 3 . Supporting this idea, BADN and RIM1 1079-1463 significantly suppressed vesicle docking in PC12 cells (Fig. 7c) . In our experiments, however, RIM1 and b subunit targeting to the presynaptic site was observed only after early synapse formation (Fig. 3) . It is possible that the interaction of Mint and CASK with VDCC a 1 subunits via their C termini 22 
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also direct channel targeting in parallel of, or before, RIM1-b subunit complex formation. Notably, our observation is consistent with a previous report 46 stating that the loss of the RIM homolog UNC10 caused a reduction in membrane-contacting synaptic vesicles within 30 nm of the dense projection at Caenorhabditis elegans neuromuscular junctions. Furthermore, in RIM1a-deficient mice, the decay of excitatory postsynaptic currents (EPSCs) during 14-Hz trains of presynaptic stimulation is abolished, whereas the rate at which the readily releasable vesicle pool is refilled is indistinguishable between the wild-type and RIM1a mutant mice 12 . These data suggest that RIM1-mediated vesicles anchoring to VDCCs may enable a rapid depletion of vesicle pools such that the available vesicles are exhausted, leading to EPSC decay. In this scenario, RIM1 knockout would minimize rapid vesicle release, enabling the readily releasable pool to be maintained and thus prevent EPSC decay. More recently, it has been reported that mice deficient in both RIM1a and RIM2a show lethality due to defects in Ca 2+ -triggered release despite normal presynaptic active zone length and normal spontaneous neurotransmitter release 47 . In combination, these studies support our model ( Supplementary Fig. 8 ), predicting a dual function for the RIM1-b interaction in neurotransmitter release by coordinating the molecular constituents and Ca 2+ signaling in presynaptic active zones. Previous reports have demonstrated the functional impact of syntaxin, synaptosome-associated protein (SNAP-25) and synaptotagmin on VDCCs through physical association with the 'synprint' region in the II-III linker of a 1 -proteins [19] [20] [21] . It has been reported 48 that RIM associates with the synprint 10 directly via the C 2 A domain, and with the a 1 C-terminal tail indirectly via the RIM-binding protein (RIM-BP) (Fig. 1a) . However, RIM1 regulation of VDCCs may be independent of the synprint-or RIM-BP-mediated association, because RIM1 1079-1463 , which lacks both the C 2 A domain necessary for synprint binding 10 and the PXXP motif for the RIM-BP binding, is still sufficient to inhibit VDCC inactivation (Fig. 4a,c) . This is supported by our observation that BADN, or replacement of b with b 4 -GK, was sufficient to disrupt the RIM1 effects on inactivation (Supplementary Fig. 5 ). Syntaxin and SNAP-25 have been proposed to inhibit VDCC-mediated Ca 2+ influx via a hyperpolarizing shift of the inactivation curve in the absence of vesicle docking at VDCC sites 19, 21 , whereas our finding implies enhancement or maintenance of the Ca 2+ influx via interaction with RIM1 during the docking of vesicles. Notably, previous reports suggest that RIM1 is involved in the modification of the release apparatus at a late stage in the vesicle cycle 9 , particularly in the postdocking step 49 . In early phases of vesicle docking, VDCC a 1 interactions with syntaxin and SNAP25 (refs. 19-21) and Mint and CASK 22, 23 may be important, eliciting partial resistance to BADN suppression of vesicle docking (Fig. 7c) . Thus, the a 1 protein associations and the RIM1-b association may be distinct interactions that contribute at different stages of vesicle cycling to controlling the Ca 2+ supply from the source, namely the VDCC, in addition to regulating the proximity between the Ca 2+ source VDCC and the target Ca 2+ sensors at the presynaptic active zone.
METHODS
cDNA expression, cell culture, molecular modeling, recombinant proteins and infection with Sindbis viruses. Methods for cDNA cloning and expression, cell culture, molecular modeling of BADN, preparation of GST fusion proteins and purified b 4b -subunit recombinants, and the preparation and infection of Sindbis viruses can be found in the Supplementary Methods online.
Yeast two-hybrid screening and b-galactosidase assay. We subcloned rat b 4b subunit (GenBank accession number XM_215742) into pGBK-T7 and used it as a bait to screen a mouse brain pACT2 library in the yeast strain AH109 (Clontech). We plated transformants (1.5 Â 10 6 ) on synthetic medium lacking adenine, histidine, leucine and tryptophan and assayed His + colonies for b-galactosidase activity with a filter assay. Of the transformants, 103 were His + , and 21 of these were also LacZ + . We isolated prey clone no. 2-5, encoding RIM1 1079-1463 (NM_053270).
In vitro binding of the purified proteins, GST-pulldown and coimmunoprecipitation experiments. RIM1-GST fusion proteins at various concentrations were incubated with 50 pM purified recombinant b 4 subunits for 3 h at 4 1C. Proteins were subjected to western blotting with an antibody for b 4 raised against the peptide ENYHNERARKSRNRLS. The densities of protein signals, obtained using NIH Image (National Institute of Mental Health) under the linear relationship with the applied amount of proteins ( Supplementary  Fig. 2 ), were normalized to the densities from the maximal binding. For the pulldown assays, the cell lysate was incubated with glutathione-Sepharose beads bound to purified fusion proteins. The proteins were characterized by western blotting with antibody for Myc (Invitrogen). For coimmunoprecipitation, the cell lysate was incubated with anti-FLAG M2 monoclonal antibody (Sigma), and the immunocomplexes were characterized by western blotting with antibody for Myc. For details, see Supplementary Methods.
Biochemistry of native neuronal VDCC complexes. VDCC complexes were partially purified from the brains of C57BL/6 or lethargic mice (B6EiC3Sn-a/ A-Cacnb4 lh /J, Jackson Laboratory) as previously reported 25 . KCl washed microsomes (50 mg) were solubilized in buffer I (for buffers, see Supplementary Table 8 online) and centrifuged at 142,000g for 37 min. The supernatant was incubated with heparin-agarose (Sigma); agarose was washed with buffer II and III before elution with buffer IV. After elution, samples were diluted to 150 mM NaCl by addition of buffer V and concentrated using centrifugal filter devices (Millipore). The samples were applied to 5-40% sucrose density gradients (buffer VI) and were centrifuged at 215,000g for 90 min. Western blots were performed using antibodies for RIM (BD Biosciences), Ca v 2.1 (Alamone), syntaxin (Sigma) and b 4 (described above). Western blot band densities (NIH image) were normalized from four to five independent experiments.
For immunoprecipitation, partially purified neuronal VDCC complexes were incubated with protein A-agarose coupled to antibodies for b 4 or RIM1 4 . Immunoprecipitated proteins were subject to western blotting with TIRF imaging. PC12 cells cotransfected with 1 mg pVenus-N1-NPY and RIM1 expression plasmids at the equal molar quantity (5.0 mg RIM1 11-399, 5.7 mg RIM1 400-1078 , 5.0 mg RIM1 1079-1463 or 7.5 mg RIM1) and BADN (10 mg) using OptiFect (Invitrogen) were plated onto poly-L-lysine-coated coverslips. PCR analysis showed that the RIM plasmids were transfected at the equal level ( Supplementary Fig. 7 ). The imaging was performed in modified Ringer's buffer. Fluorescence images of NPY-Venus were taken at the single vesicle level using an inverted microscope (IX71, Olympus). Incident light for total internal reflection illumination was introduced from the high numerical objective lens through a single mode optical fiber. Images were captured by a cooled CCD camera (EM-CCD, Hamamatsu Photonics). Area calculations and fluorescent spot counting were performed using Metamorph software (Molecular Devices).
The cells showing distribution of vesicles with o10 mm 2 dark circle area that can be placed in between vesicles were selected as cells with uniformly distributed vesicles. The maximal dark circle area in the images from BADNtransfected cells with uniform vesicle distribution was 10 mm 2 . For details, see the Supplementary Methods.
Immunostaining of cultured hippocampal neurons. Culture and transfection of mouse hippocampal neurons were carried out as described 50 . EGFP-tagged Ca v 2.1, Myc-tagged RIM1 and FLAG-tagged b 4b were detected with a Zeiss LSM510META confocal microscope using a combination of antibodies: FLAG M2 monoclonal, Myc polyclonal (Cell Signaling) and Alexa488-and Alexa594-conjugated secondary antibodies (Invitrogen). See the Supplementary Methods for further quantification procedures. Suppression of the action of endogenous RIMs using siRNAs and BADN in PC12 cells. The sense siRNA sequences 5¢-AAGAATGGACCACAAATGCTT-3¢ and 5¢-AAGGTGATTGGATGGTATAAA-3¢ for rat RIM1, and 5¢-AAGGC CCAGATACTCTTAGAT-3¢ and 5¢-AAGAACTATCCAACATGGTAA-3¢ for rat RIM2, were used. Suppression of RNA expression was confirmed by RT-PCR analyses ( Supplementary Fig. 7 ). The cells transfected with 8.0 mg pCI-neo-BADN or 8.0 mg pCI-neo-RIM1 were subjected to current recordings 72-96 h after transfection. For details, see the Supplementary Methods.
Release assay and RNA analysis in PC12 cells. RNA expression of the a 1 subunits, b subunits, RIM1 or RIM2 in PC12 cells was determined by RT-PCR (Supplementary Fig. 7 ; see Supplementary Note: Supplementary information is available on the Nature Neuroscience website.
